Monogram Orthopedics Inc. (MGRM) Narxning foydaga nisbati

Monogram Technologies Inc - MGRM emitenti grafik logotipi

Bozor baholovini tasdiqlovchi ushbu narxlar grafigi Monogram Technologies (MGRM) uchun PE ko'rsatkichi -11.60 ekanligini ko'rsatmoqda. Monogram Technologies aksiyalar opsion dasturlari va saxovatli R&D investitsiyalari orqali yetakchi robototexniklarni jalb qilmoqda. Biznes shaxsiylashtirilgan bo'g'im protezlari uchun AI tizimiga tayanadi, bu esa kompaniyaga narxlarni belgilash imkoniyatini beradi. Uning xususiy 3D chop etish texnologiyasi himoya to'sig'ini yaratadi va uning muvaffaqiyati AQSh tibbiyot markazlarining qamrov darajasiga bog'liq.

Monogram Orthopedics (MGRM) - P/E multiplikatori 21.02.2024dan 18.10.2025gacha

Monogram Technologies kompaniyasining tahliliy kesimlari

- narx va narxlar bo'yicha konsensus prognoz:
Kompaniyaning umumiy tahlili:monogramorthopedics.com, MGRM
Monogram Technologies tovar namunasi

P/E koeffitsiyenti bozor kapitalizatsiyasi va sof foyda o'rtasidagi bog'liqlikni aks ettirib, joriy daromadning har bir dollari uchun to'lanadigan xarajatni o'lchaydi. Ushbu metrika biznesning kengayish sur'atlari bo'yicha kelajakdagi bozor kutuvlarini chegiralaydi. P/E koeffitsiyenti tendentsiyasini tahlil qilish orqali investor kichik kapitalizatsiyali aktivlarning haddan tashqari qimmat baholanganligini aniqlashi mumkin. Monogram Technologies (MGRM) uchun ushbu ko'rsatkich robototexnika tizimlari ishlab chiqarish va xizmat ko'rsatish uchun autsorsing modelining samaradorligini baholaydi.

Raqobatdosh kompaniyalar tahlili

P/E multiplikatori intuitive.com|Narxning foydaga nisbati Danaher (DHR)|Narxning foydaga nisbati BDX (BD)|STERIS Corporation - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati WST|Baxter International - P/E multiplikatori|Biznesning o‘zini qoplash muddati masimo.com MASI|Stevanato Group (STVN) - Narxning foydaga nisbati|Narx-foyda multiplikatori TFX|Narxning foydaga nisbati Merit Medical Systems Inc|Nobel Biocare (NVST) - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti ICUI (ICU Medical, Inc.)|Bozor narxining sof foydaga nisbati XRAY|Narxning foydaga nisbati LeMaitre Vascular LMAT|Kompaniya qiymatining sof foydaga nisbati ATRC|STAA: Narx-foyda koeffitsiyenti|NAGE - P/E multiplikatori|ZimVie Inc. (ZIMV) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti angiodynamics.com|CERS (Cerus) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Alpha Teknova TKNO|Narxning foydaga nisbati Sharps Technology, Inc. (STSS)|infusystem.com - Narx-foyda multiplikatori|Utah Medical Products - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati KRMD (KORU Medical Systems, Inc.)|NYXH - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati Microbot Medical, Inc. MBOT|Pro-Dex Corp (PDEX) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Zentek Corp|Narxning foydaga nisbati Elutia Inc.|Kapitalizatsiyaning foydaga nisbati milestonescientific.com MLSS|Narxning foydaga nisbati NEXGEL (NXGL)|retractable.com - Narx-foyda multiplikatori|Narxning foydaga nisbati Harvard Bioscience HBIO|Femasys Corporation (FEMY) - Kapitalizatsiyaning foydaga nisbati|Meihua Medical - P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti Predictive Oncology (POAI)|callanjmb.com (CJMB) - Narxning foydaga nisbati|Atrion Corp. - Kompaniya qiymatining sof foydaga nisbati|NURO (NeuroMetrix Corp) - P/E multiplikatori